[1]
A. Marocco, S. Stanisic, F. Fanelli, F. Damele, and F. Colivicchi, “Alirocumab in the management of primary hypercholesterolaemia or mixed dyslipidaemia: A budget impact analysis – Italian perspective”, Grhta, vol. 5, no. 1, Jul. 2018.